The role of early screening

 

Since hepatitis B and  C is asymptomatic, it is often undiagnosed until decades later when the liver is severely damaged. In fact, 1 in 4 patients with chronic hepatitis B and  C will develop complications such as cirrhosis, liver failure or liver cancer, leading to the majority of liver transplant cases.

 

Early screening helps to identify patients and serves to:

 

- Assess the degree of liver damage

- Determine viral genotype to guide treatment

- Increase treatment success rate

- Reduce complications and transmission